Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17698855&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects Argraves KM; Argraves WSJ Lipid Res 2007[Nov]; 48 (11): 2325-33The lysosphingolipid sphingosine 1-phosphate (S1P) is a component of HDL. Findings from a growing number of studies indicate that S1P is a mediator of many of the cardiovascular effects of HDL, including the ability to promote vasodilation, vasoconstriction, and angiogenesis, protect against ischemia/reperfusion injury, and inhibit/reverse atherosclerosis. These latter cardioprotective effects are being shown to involve the S1P-mediated suppression of inflammatory processes, including reduction of the endothelial expression of monocyte and lymphocyte adhesion molecules, decreased recruitment of polymorphonuclear cells to sites of infarction, and blocking of cardiomyocyte apoptosis after myocardial infarction. This review article summarizes the evidence that S1P as a component of HDL serves to regulate vascular cell and lymphocyte behaviors associated with cardiovascular (patho)physiology.|ATP-Binding Cassette Transporters/physiology[MESH]|Animals[MESH]|Atherosclerosis/etiology[MESH]|Cardiovascular System/*drug effects[MESH]|Cell Movement/drug effects[MESH]|Cystic Fibrosis Transmembrane Conductance Regulator/physiology[MESH]|Endothelial Cells/drug effects/physiology[MESH]|Humans[MESH]|Immunologic Factors/physiology[MESH]|Lipoproteins, HDL/*physiology[MESH]|Lysophospholipids/*physiology[MESH]|Muscle, Smooth, Vascular/physiology[MESH]|Phosphotransferases (Alcohol Group Acceptor)/blood[MESH]|Reperfusion Injury/prevention & control[MESH]|Signal Transduction/*physiology[MESH]|Sphingosine/*analogs & derivatives/physiology[MESH]|Vasoconstriction/physiology[MESH]|Vasodilation/physiology[MESH] |
